Hyperbaric Oxygen Therapy for the Treatment of Gas Gangrene
Hyperbaric Oxygen Therapy (HBOT) offers a proven, life-saving treatment for gas gangrene, a dangerous bacterial infection. Learn how HBOT inhibits bacteria, neutralizes toxins, and promotes healing, reducing the risk of amputation. Discover clinical evidence and why Oxyair hyperbaric chambers are trusted by medical centers worldwide.
Apr 30th,2025275 Views
Hyperbaric Oxygen Therapy for the Treatment of Gas Gangrene
What is gas gangrene?
According to statistics, approximately 1,000 cases of gas gangrene are reported in the United States each year. Also known as clostridial myonecrosis, gas gangrene is a rapidly progressing and life-threatening bacterial infection commonly seen in trauma cases, post-surgical wounds, or patients with diabetes. The bacteria multiply in the injured tissue, releasing toxins that cause tissue necrosis and generate gas, hence the name "gas" gangrene. Traditional treatments like surgical debridement and antibiotics are essential in the face of such a severe infection. However, modern medicine has proven that Hyperbaric Oxygen Therapy (HBOT) plays a crucial supportive role in the treatment of gas gangrene.
Mechanism of Hyperbaric Oxygen Therapy
Hyperbaric Oxygen Therapy (HBOT) involves the patient breathing pure oxygen in an environment higher than atmospheric pressure. This process significantly increases the amount of dissolved oxygen in the blood, thereby improving oxygen delivery to tissues. Gas gangrene is a specific type of necrotizing muscle tissue injury commonly caused by anaerobic bacterial infections. Under hyperbaric conditions, bacterial growth can be inhibited, as the high-oxygen environment is unfavorable for anaerobic bacteria. Therefore, HBOT is commonly used as an adjunctive treatment for gas gangrene.
How Hyperbaric Oxygen Therapy Treats Gas Gangrene
Inhibits Anaerobic Bacterial Growth:
Anaerobic bacteria such as Clostridium perfringens, the main cause of gas gangrene, thrive in low-oxygen environments. HBOT delivers high concentrations of oxygen (100% pure oxygen at pressures of 2.8 to 3.0 ATA), dramatically increasing tissue oxygen levels. This directly suppresses anaerobic bacterial metabolism and toxin production. The high-oxygen environment also blocks the release of bacterial alpha-toxin (phospholipase C), thereby reducing tissue destruction.
Neutralizes Toxins:
Hyperbaric oxygen can directly inactivate alpha-toxins already released, minimizing their damage to cell membranes and mitigating local inflammatory responses.
Improves Tissue Survival:
HBOT enhances oxygen delivery to ischemic tissues, promotes fibroblast proliferation, and boosts collagen synthesis, accelerating wound healing. Additionally, by reducing edema through oxygen-induced vasoconstriction, HBOT improves microcirculation and limits the extent of tissue necrosis.
Enhances Immune Response:
A high-oxygen environment boosts the bactericidal function of neutrophils, strengthening the body’s ability to clear infections effectively.
Clinical Studies on Hyperbaric Oxygen Therapy for Gas Gangrene
The Undersea and Hyperbaric Medical Society (UHMS) and the U.S. Food and Drug Administration (FDA) have both recognized Hyperbaric Oxygen Therapy (HBOT) as an effective adjunctive treatment for gas gangrene.
The typical treatment protocol includes:
1 to 2 HBOT sessions per day Each session lasts about 90 to 120 minutes A treatment duration of 7 to 14 days, depending on the severity of the infection
“For clostridial myositis and myonecrosis (gas gangrene) or spreading clostridial cellulitis with systemic toxicity (or a presumptive diagnosis of either), the preferred treatment is a combination of hyperbaric oxygen (HBO2), surgery, and antibiotics. The advantages of early HBO2 treatment are that:
It is life-saving because less heroic surgery needs to be performed in gravely ill patients, and the cessation of alpha-toxin production is rapid. It is limb- and tissue-saving because no major amputations or excisions are done prematurely (except opening of wounds). It clarifies the demarcation, so that within 24-30 hours, there is a clear distinction between dead and still-living tissue. In this way, both the number and the extent of amputations are reduced.”
"Clostridial myonecrosis (gas gangrene) is an uncommon sequela of traumatic injury. Infection with Clostridium perfringens in devitalized tissue is the most common cause. Wide surgical debridement and appropriate antibiotic therapy remain the standard of care. However, the addition of hyperbaric oxygen therapy to standard management has been shown to have a synergistic effect in reducing morbidity and mortality in both canine and murine models. Although no prospective human data are available, retrospective data indicate that concomitant hyperbaric oxygen therapy has resulted in a twofold reduction in mortality. Where feasible, hyperbaric oxygen therapy should routinely be incorporated into the treatment plan for gas gangrene."
Gas gangrene is a dangerous and aggressive infection that, if not treated promptly, can become life-threatening or even result in amputation. As a key treatment method, Hyperbaric Oxygen Therapy (HBOT) has proven effective in inhibiting bacteria and promoting healing, making it an indispensable option in modern clinical practice. If you are a medical institution, trauma center, or surgical department, choosing an Oxyair hyperbaric oxygen chamber will provide your patients with a higher standard of treatment and care. To learn more about our best hyperbaric chambers, feel free to contact us for detailed product information and professional consultation!
